Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Accumulated Expenses: 2016-2025

Historic Accumulated Expenses for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to $40.3 million.

  • Organogenesis Holdings' Accumulated Expenses rose 11.66% to $40.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.3 million, marking a year-over-year increase of 11.66%. This contributed to the annual value of $39.5 million for FY2024, which is 31.19% up from last year.
  • As of Q3 2025, Organogenesis Holdings' Accumulated Expenses stood at $40.3 million, which was up 52.99% from $26.3 million recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Accumulated Expenses ranged from a high of $40.3 million in Q3 2025 and a low of $25.4 million during Q1 2021.
  • Over the past 3 years, Organogenesis Holdings' median Accumulated Expenses value was $35.0 million (recorded in 2023), while the average stood at $33.9 million.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first spiked by 55.55% in 2021, then plummeted by 30.69% in 2025.
  • Quarterly analysis of 5 years shows Organogenesis Holdings' Accumulated Expenses stood at $37.3 million in 2021, then fell by 29.08% to $26.4 million in 2022, then grew by 13.71% to $30.1 million in 2023, then soared by 31.19% to $39.5 million in 2024, then grew by 11.66% to $40.3 million in 2025.
  • Its Accumulated Expenses was $40.3 million in Q3 2025, compared to $26.3 million in Q2 2025 and $31.1 million in Q1 2025.